Observational Study on CAR-T Cell Therapy and Fertility
This observational study is a survey designed to understand how CAR-T cell therapy (a type of immunotherapy where your own immune cells are modified to fight cancer) affects fertility. The study aims to gather information from people who have received CAR-T cell treatment for cancer. By collecting this data, researchers hope to improve future treatment plans and strategies for preserving fertility. You can join if you are at least 18 years old, have been diagnosed with any type of cancer, and have received CAR-T cell treatment. The main goal is to measure the impact of CAR-T cell therapy on fertility over one year.
- Study design
- This is an observational study, meaning it involves a survey to collect information from about 200 participants. It is not testing a new treatment but rather observing the effects of an existing one.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Data will be collected for one year to assess the impact of CAR-T cell therapy on fertility.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Nina Logan, MD · PRINCIPAL_INVESTIGATOR · The Leukemia and Lymphoma Society
- John J Ligon, MD · STUDY_CHAIR · Univ of Florida, Gainesville
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- The Impact of CAR-T Cell Therapy on Fertilitydata will be collected for 1 year
As there is limited knowledge regarding the impact of CAR-T Cell therapy on fertility, LLS, in collaboration with John Ligon MD and Citizen Health, has designed a Patient Survey to learn more about the impact on fertility in patients who have received/are receiving CAR-T Cell treatment. The insights gained from this survey will inform future treatment protocols and fertility preservation strategies.